chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sick; Initial information received on 09-Oct-2020 regarding an unsolicited valid non-serious case received from a social media consumer (patient).  This case involves patient (unknown demographics) who experienced sick (illness), while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment, concomitant medication, vaccination and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sick (illness), (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was reported as unknown.  There will be no information on the batch number for this case.
Patient  came to the pharmacy expressing some concerns about muscle and nerve pain after receiving vaccine on 08/26/2021. Patient explains that he had the normal injection site pain and soreness but after that he started to experience nerve pain in this arms and back.
Slowed speech - staring into space. Knees buckled. Collapsing. Arm tremors - shaking. Sleep problems. Insomnia - up every 1 hour. Having hallucinations.
Minor arm pain on 2nd day of each vaccine Diarrhea 3 days after 2nd vaccine Massive heart attack (left ventricle) 8 days (2/24/21) after vaccine Home hospice 3:30pm 2/24/21 Stopped breathing 5:45 am, pronounced dead at 8:22 am on 2/25/21
Patient reported localized reaction including redness, itchy and slightly painful. Patient noticed last evening and has not grown in size today. Pt reported the area to be 4x3 inches and no fever.
loss of taste; loss of smell; running fever 101°F; FEELING SICK; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (FEELING SICK), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and PYREXIA (running fever 101°F) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19.     Concurrent medical conditions included Hypertension.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced MALAISE (FEELING SICK) and PYREXIA (running fever 101°F). On 04-Feb-2021, the patient experienced AGEUSIA (loss of taste) and ANOSMIA (loss of smell). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DEXTROMETHORPHAN POLISTIREX (ROBITUSSIN 12 HOUR COUGH RELIEF) at an unspecified dose and frequency. At the time of the report, MALAISE (FEELING SICK) and PYREXIA (running fever 101°F) had resolved and AGEUSIA (loss of taste) and ANOSMIA (loss of smell) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include Blood Pressure Medication.
Reactive lymph nodes in underarm; Reactive lymph nodes in underarm and breast; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 19Aug2021 at 10:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa (sulfonamide) allergy and allergy to nitrates. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Aug2021 at 06:00, the patient experienced reactive lymph nodes in underarm and breast. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with pain medication (unspecified name). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event reactive lymph nodes in underarm and breast was not recovered at the time of this report.  The batch/lot number for BNT162b2, was not provided and will be requested during   follow up.
Lump & redness & itchiness on and around injection site noticed 6 days after vaccine. It?s now 8 days and lump is still there but not currently itchy.
Possible 1st dose 2019, no 2nd dose yet; This non-serious case was reported by a nurse via sales rep and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Possible 1st dose 2019, no 2nd dose yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date:11-APR-2023 The case was reported by sales representative on behalf of nurse practitioner (customer relationship management). No second dose administered. No additional adverse event details available at this time.
Fever, body aches, chills, headache and dizziness for 42 hours....missed 2 days of work.
Injection site swelling 3.5 x 1.5 x  1/4 " red itchy. Has not improved in the last 24 hours. Counseled to do cetirizine 10 mg daily and apply hydrocortisone 1% cream a couple times a day.
Patient admitted to our hospital on 6/22/21 with shortness of breath and acute hypoxic respiratory failure in the setting of COVID-19 infection.  Patient is fully vaccinated.  Patient resides in a nursing home.  Her COVID-19 did test positive for a variant by IDPH testing but IDPH would not disclose the identity of the variant when contacted.  Patient was treated with oxygen, remdesivir, and dexamethasone.  Patient improved and was discharged back to her nursing home on 6/27/21.
Red welts on his right upper body; Blotchy; Pretty painful; Looks like shingles; Looks like a bunch of spider bites; This spontaneous case was reported by a physician and describes the occurrence of RASH ERYTHEMATOUS (Red welts on his right upper body), RASH MACULAR (Blotchy), PAIN (Pretty painful), HERPES ZOSTER (Looks like shingles) and ARTHROPOD BITE (Looks like a bunch of spider bites) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Red welts on his right upper body), RASH MACULAR (Blotchy), PAIN (Pretty painful), HERPES ZOSTER (Looks like shingles) and ARTHROPOD BITE (Looks like a bunch of spider bites). At the time of the report, RASH ERYTHEMATOUS (Red welts on his right upper body), RASH MACULAR (Blotchy), PAIN (Pretty painful), HERPES ZOSTER (Looks like shingles) and ARTHROPOD BITE (Looks like a bunch of spider bites) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included blood pressure medicine and prostate medicine. Treatment information were not provided.
A report has been received from a physician concerning a 16 year old, female patient. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient started receiving a treatment with nasal FLUMIST. Two patients received FLUMIST and the above mentioned patient tested positive for influenza B. Event occurred on 10-Jan-2013. No hospitalization. The outcome of the event of Influenza B was recovered. The report was considered to be non-serious by reporter.
EXPIRED VACCINE USED; INCORRECT STORAGE OF VIAL; This spontaneous report received from a pharmacist concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported and has been requested. On 08-APR-2021, the subject experienced expired vaccine used. On 08-APR-2021, the subject experienced incorrect storage of vial. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the expired vaccine used and incorrect storage of vial was not reported. This report was non-serious. This case is a duplicate of 20210416048 and 20210416868.
Patient developed muscle pain, joint pain, headache, chills, low grade fever, and fatigue about 12 hours after injection.  Symptoms have improved but patient still feels extremely fatigued with muscle pain.  Patients wife requested that his symptoms be reported.
Arms hurt. Said there is a lump at injection site. 9/5/14 pea size lump still there. Is lessening.
Pain in shoulder of injection site. Pain increased over the next several hours. Went to Emergency Room at 12:15 AM on 11/20/2015. Given Naproxen and Tylenol and a prescription for additional Naproxen DR 500 MG Tablets QTY: 20. Also given 3 Oxycodone/APAP5/325mg (Percocet) to take as needed. I took one Oxycodone and the pain eased up enough for me to sleep that night. I could not work the next day. I could not lift my arm or use it. Gradually over the next few days I was able to raise my arm more and more until I could raise it above my head without extreme pain. Now, over 2 weeks later my arm is still sore. I continue to have trouble sleeping at night. My right shoulder is painful, sore, aching in the morning. A hot shower eases the discomfort. I took the naproxen for five or six days, and continue to take 1 at night. I also have taken ibuprofen. I called Doctor and reported the adverse reaction on the morning of 11/20/2015. I called again a few days later requesting something to help me sleep through the night. I was told to take Tylenol PM. It does not help with the pain and makes me groggy in the morning.
No adverse reaction reported. To whom it may concern: In November 2022 our state immunization program did our every-other-year audits in both our offices. It was discovered at that time, that some covid vaccines were administered outside of the 10 week expiration date (which is calculated from the date the vaccines were received from the state.) The state program directed us to fill out AVAERS forms and send them to you. The state also counseled us that it was our providers and parents joint decision as to whether to re-vaccinate pts or not. We only use Pfizer vaccines for covid-and the list lot #s given outside the expiration date are listed below.  FM0698 (orange top)      FM0698 (purple) FM0698 (purple top)       FP4554 (purple) FL8095 (orange top)      FL8094 (orange) FL8094 (orange top)      FL8095 (orange) FM7553 (purple)            FT1551 (orange) Please see the attached VAERS forms, and feel free to contact the office for further questions or concerns.
Left foot was tingling. Tingling progressed over the next few days up the left leg.Today (11/2/09)she states her left foot feels like it is asleep. 11/9/2009 record from PCP for 11/3/2009. Patient with c/o's tingling lt foot, progressing up lt leg. PE noted decreased sensation. Tx: Medrol dose pak
Pt given flu vaccine in office on 10/8/18. Did not show any redness swelling until 10/9/18. Seen in office 10/10/18. Per Dr, cool compresses and cephalexin prescribed.
The day after pt received the ZOSTAVAX vaccine she developed minor SOB, no energy and lost her voice.
Presented to the ED with 2 day history of progressive lower extremity paresthesia and subjective weakness with ambulating several days after receiving influenza vaccine.  Patient had never had a reaction to influenza in the past.  Patient denies underlying neurologic disorder. The patient was diagnosed with Guillain-Barre Syndrome.  Patient was treated with IVIG .
Headache; Low grade fever; Nausea; Arm pain; Fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 12-years-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as UNKNOWN, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache, low grade fever, nausea, arm pain and fatigue on an unspecified date about 12 hours after receiving Pfizer Covid vaccine. It was reported that the event took place after use of product. The clinical outcome of the events was unknown.  Information about batch/Lot number has been requested.
Sedation, Myalgia, Fever, Chills Narrative:   Other Relevant History:
local rxn @ shot site; area of induration > silver dollar size; c/o dizziness; BP nl; tx w/DPH w/resolution of sx; observed for 30 mins & released;No further tx required; f/u next day by phone; pt fine
This case was reported by a nurse to a sales representative and described the occurrence of arm pain at the injection site in a 48 year old female subject who was vaccinated with influenza virus vaccine for prophylaxis. On 10/26/05, the subject received the first dose of Fluarix. Information regarding previous immunization with influenza virus vaccine was not provided. On 10/26/05, at an unspecified time after vaccination with Fluarix, the subject experienced arm pain at the injection site. As of 11/10/05, the event remained unresolved. In the reporting nurse's opinion, the event was probably related to vaccination with Fluarix.  At the time of follow-up reporting, December 19, 2005, the event had improved. In the nurse's opinion, the event was related to vaccination with Fluarix. The nurse also reported that the injection of Fluarix was "possibly administered too high".
3-8 minutes after receiving Td and Hepatitis B shots, client left clinic room to lobby to pay bill (20-30 feet). He passed out with warning and fell straight backwards, suffering a severe blow to the back of his head. He was taken per ambulance to hospital where diagnosis was concussion with cerebral bleed.
After receiving HAVRIX, patient was dizzy and slumped over. Patient felt cold and turned pale. Patient was caught by clinician. Patient regained consciousness after a minutes. Patient remained in the pharmacy for 30 minutes for observation.
Dizziness, heart palpitations, headaches, joint pain, chest pain, intestinal pain
Pt developed an injection site reaction described as cellulitis following the receipt of Acel-Imune vax.
Received vaccines on 11-18-08. Thursday 11-20-08, patient started feeling weak with neck and back pain. Legs numb / tingling, trouble walking. ER visit 11-20-08  12/12/2008 Reviewed ER medical records of 11/29/2008. FINAL DX: weakness, malaise, fatigue, dehydration, myalgia, myositis, UTI Records reveal patient experienced nausea, malaise, generalized aching, numbness, tingling, weakness & aching in legs, difficulty walking x 1 day.
LOW TEMP. CONSTANT SCREAMING FOR MORE THAN 3 HRS. PER DR ALLERGY TO PERTUSSIS.
A shingles symptom with large area red rash at the left side of my body with a lot of small and big poxes, pain, fever, stomach upset after three days later since 8/7/13.
Seven days after receiving shot, left triceps became very itchy and swollen.  I had experienced mild pain in left triceps for approximately three days after shot, pain left and have had no adverse condition until today (01-19-2021).
Per incident report, "nurse gave him his flu shot.  After he left facility, he returned complaining of arm numbness to first three digits, intermittent at this time 12/04/07.  Will seek medical attention if signs and symptoms persists.
I95.9 HYPOTENSION 10/12/2021 DM 2 W KETOACIDOSIS J96.00 ACUTE RESPIRATORY FAILURE 10/12/2021 DM 2 W KETOACIDOSIS I95.9 HYPOTENSION 10/12/2021 HTN (HYPERTENSION) J96.00 ACUTE RESPIRATORY FAILURE 10/12/2021 HTN (HYPERTENSION)
vaginal bleeding; This is a spontaneous report from a contactable consumer reporting for herself. A 25-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EN6201; Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 16Feb2021 14:30 (at the age of 25-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history and concomitant medications included none. The patient experienced vaginal bleeding on 17Feb2021. The patient underwent lab tests and procedures which included TB skin test with unknown result on 10Feb2021. It was reported that patient had a TB skin test last Wednesday at the time of this report. Caller received vaccine and then on morning of this report, had some vaginal bleeding. She wanted to know if this was a reported side effect. The patient was taking Pfizer-BioNTech as she works in a healthcare facility and stated she was a receptionist and does the billing. She got the first dose of the Pfizer BioNTech vaccine the day before this report. On 17Feb2021, the day of this report, she went to the restroom. And when she wiped, she had blood coming out. She has had her menstrual cycle this month. She was unsure if this was a side effect or if she needed to go get checked out. Physician address, phone and email are unknown to caller. There was one little spot on the pad. The blood comes out when she wipes. It was red in color. History of all previous immunization with the Pfizer vaccine considered as suspect and additional vaccines administered on same date of the Pfizer Suspect, investigation assessment or relevant Tests included none. AE did not require a visit to Emergency Room or Physician Office. Outcome of the event was not recovered and ongoing at the time of this report.  Follow-up attempts completed. No further information expected.
Mother reported seizure occurred during school, patient dropped pencil and fell to floor from desk, had 4 convulsions, teacher let him rest for 1.5 minutes, then called his name while rubbing his back and he responded, was taken to school office where he rested and his parents were contacted. Mother called clinic at 2:54 PM to report incident, per provider I instructed patient's mother to take him to the local emergency department.
Information has been received from a third party claims administrator on behalf of a pharmacy, concerning a male customer (age not reported) who on an unspecified date was vaccinated with the flu vaccine (manufacturer unspecified) and PNEUMOVAX23 and had an adverse reaction. The "date of loss" was reported as 03OCT2013. The Lot # reported for PNEUMOVAX23 was J004747. The expiration date reported as "2/14". (The expiration date in MARRS auto filled as 20JULY2014 based on the lot #). It was reported that it was unclear which vaccine he had the reaction to. Treatment and outcome of the adverse experience was unknown. Additional information has been requested.
2 days after receiving 1st dose of Moderna, patient's Blood pressure, which had been under control with listed medications, started to increase.  Face became flush, patient contacted cardiology, Dr.  who put him on a heart monitor for 48 hours.  After returning monitor, patient called physician who increased carvedilol from 12.5 to 25 bid, and the amlodipine/benazepril down to 1 daily, and added valsartan 160mg  .patient's blood pressure has failed to respond to therapy changes and is undergoing further testing.   His PCP, Dr. discussed it with patient, and wants to make sure VAERS is filled out.  Dr. states that all lab values are good, but BP is still elevated.  Dr. has referred him back to cardiology again for further evaluation..
Headache, aches, fever, confusion, weak unable to walk without assistance. Dehydration.
Arm pain; This case was reported by a physician via call center representative and described the occurrence of pain in arm in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The age of patient was reported as above 16 years old. The patient experienced arm pain after receiving the vaccine. The reporter stated she does not have further details available at the time of the call. This case was 1 of the 3 linked cases, reported by same reporter.
My first one was supposed to be given deep IM but was given sub cutaneously instead. I developed inflammatory symptoms after the first injection but it was not as intense as after my second dose, which was given IM by a physician. I reported this to the PRIVATE. This time I had severe pain in my nerves, muscles, joints, and  tendons... Everywhere. I could hardly walk or go up or down 3 stairs.  Extreme diffuse pain. (Even after this 2nd dose we did not put 2 and 2 together that it was from the vaccine. We thought it might be from Armodafinil which was started at the time of my first dose of COVID and then increased at the time of my 2nd dose of COVID vaccine)
weakness; headache; chills; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), HEADACHE (headache), CHILLS (chills) and VACCINATION SITE PAIN (pain at the injection site) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced ASTHENIA (weakness), HEADACHE (headache), CHILLS (chills) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, ASTHENIA (weakness), HEADACHE (headache), CHILLS (chills) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication were not reported by the reporter. Treatment medication was not reported by the reporter.
GARDASIL 9 was administered to an unspecified 46 year old patient; No adverse effects reported; This spontaneous report was received from a pharmacist and refers to an unspecified 46-year-old patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (exact dose, injection site, route of administration, lot # and expiration date were not provided) for prophylaxis at the age of 46. No adverse event was reported.
Patient received high-dose flu vaccine instead of regular flu vaccine. They are not over 65 years of age. No s/s.